SOTERA HEALTH COMPANY (SHC) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 13.92M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 2.13B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 3.31B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $13.92M | $2.13B | (m) | (m) | $3.31B | (m) |
| 2026-03-31 | (m) | (m) | $13.98M | $2.12B | (m) | (m) | $3.24B | (m) |
| 2025-12-31 | (m) | (m) | $13.97M | $2.13B | (m) | (m) | $3.26B | (m) |
| 2025-09-30 | (m) | (m) | $13.96M | $2.13B | (m) | (m) | $3.19B | (m) |
| 2025-06-30 | (m) | (m) | $14.82M | $2.20B | (m) | (m) | $3.22B | (m) |
| 2025-03-31 | (m) | (m) | $14.81M | $2.21B | (m) | (m) | $3.10B | (m) |
| 2024-12-31 | (m) | (m) | $14.80M | $2.21B | (m) | (m) | $3.07B | (m) |
| 2024-09-30 | (m) | (m) | $14.79M | $2.21B | (m) | (m) | $3.15B | (m) |
| 2024-06-30 | (m) | (m) | $11.09M | $2.21B | (m) | (m) | $3.06B | (m) |
| 2024-03-31 | (m) | (m) | $4.81M | $2.22B | (m) | (m) | $3.06B | (m) |
| 2023-12-31 | (m) | (m) | $4.80M | $2.22B | (m) | (m) | $3.13B | (m) |
| 2023-09-30 | (m) | (m) | $5.24M | $2.22B | (m) | (m) | $3.04B | (m) |
| 2023-06-30 | (m) | (m) | $5.22M | $2.22B | (m) | (m) | $3.07B | (m) |
| 2023-03-31 | (m) | (m) | $4.03M | $2.22B | (m) | (m) | $3.41B | (m) |
| 2022-12-31 | (m) | (m) | $197.12M | $1.75B | (m) | (m) | $3.12B | (m) |
| 2022-09-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | $2.81B | (m) |
| 2022-03-31 | (m) | (m) | (m) | $1.74B | (m) | (m) | $2.84B | (m) |
| 2021-12-31 | (m) | (m) | (m) | $1.74B | (m) | (m) | $2.79B | (m) |
| 2021-03-31 | (m) | (m) | (m) | $1.84B | (m) | (m) | $2.78B | (m) |
| 2020-12-31 | (m) | (m) | (m) | $1.82B | (m) | (m) | $2.76B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |